Authored By: Sarah
29 Sep 2023

An Increasing prevalence of STDs and favorable international programs are boosting the Africa HIV Treatment Drugs Market | Forecast for 2023-2027|Technavio

Africa HIV Treatment Drugs Market is likely to experience steady growth because of the increasing prevalence of STDs and favorable international programs. Rising at a CAGR of 3.76%, the market is estimated to have an incremental growth of USD 321.6 Mn in revenue from 2023 to 2027.

Some of the leading companies contributing to this market growth are Alpha Pharma, Aspen Pharmacare Holdings Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Avacare Health, Boehringer Ingelheim International GmbH, Cipla Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hetero Labs Ltd., Johnson & Johnson, Merck & Co. Inc., SSI Diagnostica AS, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Our report includes the categorization of the core companies as pure play, category-focused, industry-focused, and diversified with a wider understanding of the business ecosystem.

 africa hiv treatment drugs market size, africa hiv treatment drugs market report, africa hiv treatment drugs market research, africa hiv treatment drugs market analysis

Africa HIV Treatment Drugs Market Analysis at a Glance


As per a Technavio analyst: the “Quote” reason is expected to boost the growth of the HIV treatment drugs market in Africa

Technavio’s recent analysis of  "the HIV treatment drugs market in Africa includes a detailed examination of its revenue forecasts, including market drivers and challenges, key market participants, and growth opportunities along with data backed by a study of the market segments in Africa, during the forecast period."  Refer to our sample report for more insights.

Lack of diagnosis of HIV access to modern medication and Social stigma associated with STDs are expected to hinder the growth of the market. However, an increase in awareness by various organizations and a growing focus on the elimination of mother-to-child transmission of HIV will have a positive impact on the HIV treatment drugs market in Africa during the forecast period.

Technavio’s analysis of the HIV treatment drugs market in Africa also includes:

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will drive the HIV treatment drugs market in Africa growth during the next five years
  • Precise estimation of the HIV treatment drugs market in Africa size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the HIV treatment drugs market in the African industry across 
  • A thorough analysis of the market’s competitive landscape
  • Comprehensive details of factors that will challenge the growth of the HIV treatment drugs market in Africa
Read News Read Less
Interested in this report?
Get your sample now!
Technavio